Authors: SCHWARTZ GG OLIVER MF EZEKOWITZ MD GANZ P WATERS D KANE JP TEXTER M PRESSLER ML BLACK D CHAITMAN BR OLSSON AG

Citation: Gg. Schwartz et al., RATIONALE AND DESIGN OF THE MYOCARDIAL-ISCHEMIA REDUCTION WITH AGGRESSIVE CHOLESTEROL-LOWERING (MIRACL) STUDY THAT EVALUATES ATORVASTATIN IN UNSTABLE ANGINA-PECTORIS AND IN NON-Q-WAVE ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 81(5), 1998, pp. 578-581

Authors: CANTER D FRANK GJ KNAPP LE PHELPS M QUADE M TEXTER M

Citation: D. Canter et al., QUINAPRIL AND HYDROCHLOROTHIAZIDE COMBINATION FOR CONTROL OF HYPERTENSION - ASSESSMENT BY FACTORIAL DESIGN, Journal of human hypertension, 8(3), 1994, pp. 155-162

Authors: MILLER MA TEXTER M GMEREK A ROBBINS J SHURZINSKE L CANTER D

Citation: Ma. Miller et al., QUINAPRIL HYDROCHLORIDE EFFECTS ON RENAL-FUNCTION IN PATIENTS WITH RENAL DYSFUNCTION AND HYPERTENSION - A DRUG-WITHDRAWAL STUDY, Cardiovascular drugs and therapy, 8(2), 1994, pp. 271-275

Authors: TEXTER M LEES RS PITT B DINSMORE RE UPRICHARD ACG

Citation: M. Texter et al., THE QUINAPRIL ISCHEMIC EVENT TRIAL (QUIET) DESIGN AND METHODS - EVALUATION OF CHRONIC ACE INHIBITOR THERAPY AFTER CORONARY-ARTERY INTERVENTION, Cardiovascular drugs and therapy, 7(2), 1993, pp. 273-282